# Safety Study of hMaxi-K Gene Transfer to Treat Overactive Bladder and Detrusor Overactivity

> **NCT00495053** · PHASE1 · TERMINATED · sponsor: **Urovant Sciences GmbH** · enrollment: 21 (actual)

## Conditions studied

- Overactive Bladder

## Interventions

- **DRUG:** hMaxi-K
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00495053
- **Lead sponsor:** Urovant Sciences GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-04
- **Primary completion:** 2008-07
- **Final completion:** 2009-11
- **Target enrollment:** 21 (ACTUAL)
- **Why stopped:** Slow enrollment and financial issues
- **Last updated:** 2019-06-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00495053

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00495053, "Safety Study of hMaxi-K Gene Transfer to Treat Overactive Bladder and Detrusor Overactivity". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00495053. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*